MARTIN-LUTHER-UNIVERSITAET HALLE-WITTENBERG
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 24 Total Citation Count
- Feb 09, 2004 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0151,334 INJECTABLE AND IMPLANTABLE CARRIER SYSTEMS BASED ON MODIFIED POLY(DICARBOXYLIC ACID MULTI-OIL ESTERS) FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTApr 22, 15Jun 01, 17[A61K, C08G]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9901570 Breast cancer cell growth-inhibiting enzyme inhibitors, method for the production thereof, and use thereofAug 21, 14Feb 27, 18[A61K, C07D]
9885052 Method for the oral/mucosal vaccination by means of recombinant yeastsNov 13, 09Feb 06, 18[A61K, C12N, G01N, C07K]
9725669 Synergistic mixtures of ionic liquids with other ionic liquids and/or with ashless thiophosphates for antiwear and/or friction reduction applicationsMay 07, 13Aug 08, 17[C10M]
8980933 Combretastatin analogs for use in the treatment of cancerMay 05, 11Mar 17, 15[A61K, C07D, A61N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0311,661 USE OF COMPOUNDS DERIVED FROM CYCLOHEXIMIDE FOR THE TREATMENT OR PREVENTION OF, IN PARTICULAR, ISCHAEMIAS AND CARDIOPATHIESAbandonedAug 24, 07Dec 09, 10[A61K, A01N, A61P]
2007/0032,440 Oligonucleotides directed against a survivin gene and use thereofAbandonedFeb 09, 04Feb 08, 07[A61K, C07H]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.